Task: Answer the multiple-choice question.
Question: Which drug exhibits a -42.309% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCOC(=O)N1CCN(C(=O)CCSc2ccc(Cl)cc2)CC1
b: CN(C)C(=O)CN1C(=O)C2CC=C(Cl)CC2C1=O
c: COC(=O)c1cccc2c1-c1ccccc1/C2=N\NC(N)=O
Answer: a. CCOC(=O)N1CCN(C(=O)CCSc2ccc(Cl)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCN(C(=O)CCSc2ccc(Cl)cc2)CC1
CCOC(=O)N1CCN(C(=O)CCSc2ccc(Cl)cc2)CC1
ethyl4-[3-(4-chlorophenyl)sulfanylpropanoyl]piperazine-1-carboxylate